NASDAQ:TLRYTilray Stock Price, Forecast & News

Tilray's stock was trading at $7.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TLRY stock has decreased by 1.8% and is now trading at $6.96. View which stocks have been most impacted by Coronavirus.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tilray.

Tilray is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Tilray.

Tilray Inc (NASDAQ:TLRY) announced its quarterly earnings data on Monday, May, 11th. The company reported ($1.73) EPS for the quarter, missing the consensus estimate of ($0.44) by $1.29. The business earned $52.20 million during the quarter, compared to analysts' expectations of $49.37 million. Tilray had a negative net margin of 241.79% and a negative return on equity of 62.82%. The firm's revenue was up 127.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.27) EPS. View Tilray's earnings history.

16 analysts have issued 1 year price targets for Tilray's stock. Their forecasts range from $4.00 to $31.00. On average, they anticipate Tilray's stock price to reach $12.77 in the next year. This suggests a possible upside of 83.5% from the stock's current price. View analysts' price targets for Tilray.

Media coverage about TLRY stock has trended negative recently, according to InfoTrie. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tilray earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an impact on the company's share price in the near term. View the latest news about Tilray.

Some companies that are related to Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Aphria (APHA), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), FitLife Brands (FTLF), True Drinks (TRUU) and GLG Life Tech (GLGLF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), Advanced Micro Devices (AMD), Aphria (APHA) and Square (SQ).

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TLRY stock can currently be purchased for approximately $6.96.

Tilray has a market capitalization of $869.03 million and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe.

The official website for Tilray is www.tilray.com.

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.